Oct 9, 2020

Featuring a discussion on recent advances in the treatment of Hodgkin lymphoma with Dr Craig Moskowitz, including the following topics:

• Hodgkin lymphoma 2020: What are the important questions in up-front therapy? — Craig Moskowitz, MD (00:00)
• Case: A woman in her early 20s with relapsed/refractory Stage IV classical Hodgkin lymphoma (HL) receives pembrolizumab/gemcitabine/vinorelbine/doxorubicin (21:48)
• Case: A man in his early 20s with primary refractory Stage IV HL attains a complete response with brentuximab vedotin (BV) and nivolumab (25:04)
• Case: A woman in her early 30s with newly diagnosed Stage IIIA classical HL is enrolled on the Phase III SWOG-S1826 trial evaluating AVD (doxorubicin/vinblastine/dacarbazine) in combination with BV or nivolumab (30:56)

CME information and select publications